@StanMehr @dgingery Placement in preferred formulary tier should be lowest NET cost drug (after rebates) PERIOD. Based on tier placement in commercial formularies, it looks like $JNJ reference drug Remicade is lowest net cost drug relative to biosimilar $PFE Inflectra